These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20155974)

  • 1. Practical synthesis of a Cathepsin S inhibitor: route identification, purification strategies, and serendipitous discovery of a crystalline salt form.
    Deng X; Liang JT; Peterson M; Rynberg R; Cheung E; Mani NS
    J Org Chem; 2010 Mar; 75(6):1940-7. PubMed ID: 20155974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 1.
    Liu H; Tully DC; Epple R; Bursulaya B; Li J; Harris JL; Williams JA; Russo R; Tumanut C; Roberts MJ; Alper PB; He Y; Karanewsky DS
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4979-84. PubMed ID: 16183279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S.
    Chatterjee AK; Liu H; Tully DC; Guo J; Epple R; Russo R; Williams J; Roberts M; Tuntland T; Chang J; Gordon P; Hollenbeck T; Tumanut C; Li J; Harris JL
    Bioorg Med Chem Lett; 2007 May; 17(10):2899-903. PubMed ID: 17382545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of selective, nonpeptidic nitrile inhibitors of cathepsin s using the substrate activity screening method.
    Patterson AW; Wood WJ; Hornsby M; Lesley S; Spraggon G; Ellman JA
    J Med Chem; 2006 Oct; 49(21):6298-307. PubMed ID: 17034136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of selective Cathepsin inhibitors.
    Bethel PA; Gerhardt S; Jones EV; Kenny PW; Karoutchi GI; Morley AD; Oldham K; Rankine N; Augustin M; Krapp S; Simader H; Steinbacher S
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4622-5. PubMed ID: 19616430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New potent cathepsin G phosphonate inhibitors.
    Sieńczyk M; Lesner A; Wysocka M; Legowska A; Pietrusewicz E; Rolka K; Oleksyszyn J
    Bioorg Med Chem; 2008 Oct; 16(19):8863-7. PubMed ID: 18805698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and SAR of arylaminoethyl amides as noncovalent inhibitors of cathepsin S: P3 cyclic ethers.
    Tully DC; Liu H; Chatterjee AK; Alper PB; Epple R; Williams JA; Roberts MJ; Woodmansee DH; Masick BT; Tumanut C; Li J; Spraggon G; Hornsby M; Chang J; Tuntland T; Hollenbeck T; Gordon P; Harris JL; Karanewsky DS
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5112-7. PubMed ID: 16876402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors: part 1.
    Lee-Dutra A; Wiener DK; Arienti KL; Liu J; Mani N; Ameriks MK; Axe FU; Gebauer D; Desai PJ; Nguyen S; Randal M; Thurmond RL; Sun S; Karlsson L; Edwards JP; Jones TK; Grice CA
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2370-4. PubMed ID: 20153648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Cyano-pyrimidines: a new chemotype for inhibitors of the cysteine protease cathepsin K.
    Altmann E; Aichholz R; Betschart C; Buhl T; Green J; Irie O; Teno N; Lattmann R; Tintelnot-Blomley M; Missbach M
    J Med Chem; 2007 Feb; 50(4):591-4. PubMed ID: 17256925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazole-based cathepsin S inhibitors with arylalkynes as P1 binding elements.
    Ameriks MK; Axe FU; Bembenek SD; Edwards JP; Gu Y; Karlsson L; Randal M; Sun S; Thurmond RL; Zhu J
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6131-4. PubMed ID: 19773165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A practical enantioselective synthesis of odanacatib, a potent Cathepsin K inhibitor, via triflate displacement of an alpha-trifluoromethylbenzyl triflate.
    O'Shea PD; Chen CY; Gauvreau D; Gosselin F; Hughes G; Nadeau C; Volante RP
    J Org Chem; 2009 Feb; 74(4):1605-10. PubMed ID: 19140725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of cathepsin K inhibitors containing a benzyloxy-substituted benzoyl peptidomimetic.
    Thompson SK; Smith WW; Zhao B; Halbert SM; Tomaszek TA; Tew DG; Levy MA; Janson CA; DAlessio KJ; McQueney MS; Kurdyla J; Jones CS; DesJarlais RL; Abdel-Meguid SS; Veber DF
    J Med Chem; 1998 Oct; 41(21):3923-7. PubMed ID: 9767629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keto-1,3,4-oxadiazoles as cathepsin K inhibitors.
    Palmer JT; Hirschbein BL; Cheung H; McCarter J; Janc JW; Yu ZW; Wesolowski G
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2909-14. PubMed ID: 16546382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serendipitous discovery of novel bacterial methionine aminopeptidase inhibitors.
    Evdokimov AG; Pokross M; Walter RL; Mekel M; Barnett BL; Amburgey J; Seibel WL; Soper SJ; Djung JF; Fairweather N; Diven C; Rastogi V; Grinius L; Klanke C; Siehnel R; Twinem T; Andrews R; Curnow A
    Proteins; 2007 Feb; 66(3):538-46. PubMed ID: 17120228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and investigation of dihydroxychalcones as calpain and cathepsin inhibitors.
    Baek KH; Karki R; Lee ES; Na Y; Kwon Y
    Bioorg Chem; 2013 Dec; 51():24-30. PubMed ID: 24095934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of alpha-ketoamides as cathepsin S inhibitors with potential applications against tumor invasion and angiogenesis.
    Chen JC; Uang BJ; Lyu PC; Chang JY; Liu KJ; Kuo CC; Hsieh HP; Wang HC; Cheng CS; Chang YH; Chang MD; Chang WS; Lin CC
    J Med Chem; 2010 Jun; 53(11):4545-9. PubMed ID: 20481438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical asymmetric synthesis of a potent Cathepsin K inhibitor. Efficient palladium removal following Suzuki coupling.
    Chen CY; Dagneau P; Grabowski EJ; Oballa R; O'Shea P; Prasit P; Robichaud J; Tillyer R; Wang X
    J Org Chem; 2003 Apr; 68(7):2633-8. PubMed ID: 12662032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitors.
    Tully DC; Liu H; Chatterjee AK; Alper PB; Williams JA; Roberts MJ; Mutnick D; Woodmansee DH; Hollenbeck T; Gordon P; Chang J; Tuntland T; Tumanut C; Li J; Harris JL; Karanewsky DS
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5107-11. PubMed ID: 16876407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-phase parallel synthesis and SAR of 4-amidofuran-3-one inhibitors of cathepsin S: effect of sulfonamides P3 substituents on potency and selectivity.
    Ayesa S; Lindquist C; Agback T; Benkestock K; Classon B; Henderson I; Hewitt E; Jansson K; Kallin A; Sheppard D; Samuelsson B
    Bioorg Med Chem; 2009 Feb; 17(3):1307-24. PubMed ID: 19124252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diastereoselective arylithium addition to an alpha-trifluoromethyl imine. Practical synthesis of a potent cathepsin K inhibitor.
    Roy A; Gosselin F; O'Shea PD; Chen CY
    J Org Chem; 2006 May; 71(11):4320-3. PubMed ID: 16709080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.